Should Biotech Be On The Critical List?

The risk-off market has played havoc with the biotechs where the fundamentals have not changed as much as the valuation.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.